Nisha Pandey

New Experimental Drugs Show Promise In Targeting Tumour Dormancy & Preventing Cancer From Returning

New Experimental Drugs Could Help Prevent Cancer From Returning: Study

<a href="https://www.healthandme.com/health/cancer">Cancer</a> recurrence remains one of the biggest challenges in cancer treatment. Dormant tumour cells are capable of surviving treatment and therapy and can reactivate months or even years later.

Now, researchers say that a new generation of experimental drugs designed to target these dormant cancer cells could offer a promising strategy to prevent the disease from recurring.

The findings come as scientists have been increasingly focusing on tumour dormancy, a state in which cancer cells stop actively multiplying but remain hidden in the body. They become resistant to chemotherapy and other conventional cancer treatments.

The research suggests that targeting the biological pathways controlling dormancy may help stop these cells from getting reactivated and forming new tumours or metastases.

According to researchers, dormant cancer cells are one of the key reasons why some patients experience relapse long after completing treatment.

"Dormant tumour cells are a major driver of <a href="https://www.healthandme.com/health-wellness/experiencing-breathlessness-persistent-cough-experts-explain-when-they-could-be-signs-of-lung-cancer-article-155231151" data-type="tilCustomLink">cancer</a> recurrence and metastasis," the researchers noted, stating that therapies aimed at controlling or eliminating these cells could change how cancer is treated and managed in the future.

Also read: <a href="https://www.healthandme.com/health-wellness/bone-marrow-transplant-the-quiet-revolution-transforming-indias-fight-against-blood-cancers-article-155255381" data-type="tilCustomLink">Bone Marrow Transplant: The Quiet Revolution Transforming India's Fight Against Blood Cancers</a>

Unlike traditional cancer treatments that mainly attack rapidly dividing cells, these new experimental drugs target the molecular signals that allow dormant <a href="https://www.healthandme.com/health-news/uk-woman-becomes-world-first-to-receive-experimental-cell-therapy-for-ovarian-cancer-article-155234901" data-type="tilCustomLink">cancer cells</a> to survive and go unnoticed in the body.

Researchers are investigating several approaches, including blocking pathways that trigger dormant cells to become active again, disrupting the cells' survival mechanisms, and making them more vulnerable to conventional cancer therapies. 

Some experimental treatments are also being tested alongside immunotherapy to improve the body's ability to detect and destroy these hidden cells on time. 

Scientists say this approach could be especially important for cancers known to recur years after treatment, including breast, lung and certain <a href="https://www.healthandme.com/health-wellness/how-chronic-hepatitis-quietly-progresses-to-liver-cirrhosis-why-early-action-can-save-your-liver-article-155225172" data-type="tilCustomLink">gastrointestinal cancers</a>.

Also read: <a href="https://www.healthandme.com/health-news/nhs-breast-cancer-screening-misses-95-of-high-risk-young-women-in-uk-why-personalized-care-could-be-key-article-155247245" data-type="tilCustomLink">NHS Breast Cancer Screening Misses 95% Of High-Risk Young Women In UK: Why Personalized Care Could Be Key</a>

Cancer recurrence can happen when a small number of cells survive surgery, <a href="https://www.healthandme.com/health-wellness/can-fitness-hide-lung-cancer-why-even-active-people-shouldnt-ignore-symptoms-article-155225299" data-type="tilCustomLink">chemotherapy</a> or radiation. These cells may remain inactive for long periods of time before starting to grow again, eventually leading to a relapse or metastatic diseas.

Researchers believe that the environment of the tumour, immune responses, inflammation and changes in cellular structure and  metabolism all play a role in determining whether dormant cancer cells remain inactive or become aggressive again.

While the findings encourage advanced pathways for <a href="https://www.healthandme.com/health-wellness/i-wish-every-patient-knew-this-before-their-lung-cancer-diagnosis-lessons-from-an-oncologist-article-155225206" data-type="tilCustomLink">cancer treatments</a>, experts caution that most drugs that target tumour dormancy are still in the experimental or early clinical trial stage.

Rather than only treating visible tumours, future therapies may also focus on preventing hidden cancer cells from ever becoming active again, potentially reducing the risk of relapse years after successful treatment. 

More studies are needed to determine whether they can really reduce cancer recurrence and improve long-term survival in patients.

<h2>Viagra May Prevent Cancer From Spreading </h2>

Cancer Is A Rising Global Threat, Here's Why

The promising research comes after a new study found that Viagra, best known as a treatment for <a href="https://www.healthandme.com/health-wellness/prostate-cancer-nhs-englands-new-precision-radiotherapy-offers-hope-in-just-5-sessions-article-155186795" data-type="tilCustomLink">erectile dysfunction</a>, may also help stop cancer from spreading.

Researchers from the Weizmann Institute of Science in Israel found that sildenafil, the active ingredient in Viagra, may enhance a newly identified cholesterol-regulating mechanism that could be used to curb cancer metastasis.

The study, published in Cancer Research, showed that sildenafil limits cancer cells' ability to use cholesterol, an essential component of cell membranes.

Cholesterol is especially important for cancer cells that break away from the primary tumor, travel through the body, and invade distant organs. When their access to cholesterol is reduced, these cells have greater difficulty forming metastases.

Health Conditions A-Z

health

new-experimental-drugs-could-help-prevent-cancer-from-returning-study

cancer

Experimental Drugs

cancer recurrence

dormant cancer cells

tumour dormancy

cancer treatments

viagra

Cholesterol

breastfeeding-can-help-reduce-mothers-risk-of-type-2-diabetes-breast-cancer-and-more

Breastfeeding Can Help Reduce Mothers' Risk of Type 2 Diabetes, Breast Cancer and More

study-finds-how-a-common-amino-acid-may-strengthen-the-bodys-defence-against-cancer-and-viral-infections

Study Finds A Common Amino Acid May Strengthen The Body's Defence Against Cancer And Viral Infections

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Cancer recurrence remains one of the biggest challenges in cancer treatment. Dormant tumour cells are capable of surviving treatment and therapy and can reactivate months or even years later. Now, researchers say that a new generation of experimental drugs designed to target these dormant cancer cells could offer a promising strategy to prevent the disease from recurring.The findings come as scientists have been increasingly focusing on tumour dormancy, a state in which cancer cells stop actively multiplying but remain hidden in the body. They become resistant to chemotherapy and other conventional cancer treatments. The research suggests that targeting the biological pathways controlling dormancy may help stop these cells from getting reactivated and forming new tumours or metastases.According to researchers, dormant cancer cells are one of the key reasons why some patients experience relapse long after completing treatment."Dormant tumour cells are a major driver of cancer recurrence and metastasis," the researchers noted, stating that therapies aimed at controlling or eliminating these cells could change how cancer is treated and managed in the future.About The Experimental Drugs Also read: Bone Marrow Transplant: The Quiet Revolution Transforming India's Fight Against Blood CancersUnlike traditional cancer treatments that mainly attack rapidly dividing cells, these new experimental drugs target the molecular signals that allow dormant cancer cells to survive and go unnoticed in the body.Researchers are investigating several approaches, including blocking pathways that trigger dormant cells to become active again, disrupting the cells' survival mechanisms, and making them more vulnerable to conventional cancer therapies. Some experimental treatments are also being tested alongside immunotherapy to improve the body's ability to detect and destroy these hidden cells on time. Scientists say this approach could be especially important for cancers known to recur years after treatment, including breast, lung and certain gastrointestinal cancers.Why Do Some Cancers Return? Also read: NHS Breast Cancer Screening Misses 95% Of High-Risk Young Women In UK: Why Personalized Care Could Be KeyCancer recurrence can happen when a small number of cells survive surgery, chemotherapy or radiation. These cells may remain inactive for long periods of time before starting to grow again, eventually leading to a relapse or metastatic diseas.Researchers believe that the environment of the tumour, immune responses, inflammation and changes in cellular structure and  metabolism all play a role in determining whether dormant cancer cells remain inactive or become aggressive again.While the findings encourage advanced pathways for cancer treatments, experts caution that most drugs that target tumour dormancy are still in the experimental or early clinical trial stage.Rather than only treating visible tumours, future therapies may also focus on preventing hidden cancer cells from ever becoming active again, potentially reducing the risk of relapse years after successful treatment. More studies are needed to determine whether they can really reduce cancer recurrence and improve long-term survival in patients.Viagra May Prevent Cancer From Spreading          The promising research comes after a new study found that Viagra, best known as a treatment for erectile dysfunction, may also help stop cancer from spreading. Researchers from the Weizmann Institute of Science in Israel found that sildenafil, the active ingredient in Viagra, may enhance a newly identified cholesterol-regulating mechanism that could be used to curb cancer metastasis.The study, published in Cancer Research, showed that sildenafil limits cancer cells' ability to use cholesterol, an essential component of cell membranes.Cholesterol is especially important for cancer cells that break away from the primary tumor, travel through the body, and invade distant organs. When their access to cholesterol is reduced, these cells have greater difficulty forming metastases.